Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.20.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Shares Issued
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock - Number of Shares, Treasury Shares
Common Stock - Number of Shares, Treasury Shares
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjustment
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect Period of Adoption Adjustment
Retained Earnings
Cumulative Effect Period of Adoption Adjusted Balance
Balance at beginning of period at Dec. 31, 2017 $ 562,477     $ 33   $ (71,889)   $ 565,627   $ (1,869)     $ 70,575    
Balance at beginning of period (ASU 2018-02) at Dec. 31, 2017                     $ (399)     $ 399  
Balance at beginning of period (ASU 2016-01) at Dec. 31, 2017                     $ 382     (382)  
Beginning balance, shares issued (shares) at Dec. 31, 2017       33,083,133 33,083,133                    
Beginning balance, treasury stock (shares) at Dec. 31, 2017           (651,506) (651,506)                
Beginning balance, shares outstanding (shares) at Dec. 31, 2017       32,431,627 32,431,627                    
Adjusted balance at Dec. 31, 2017     $ 562,477   $ 33   $ (71,889)   $ 565,627     $ (1,886)     $ 70,592
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock options exercised 570             570              
Stock options exercised (shares)       25,750                      
Restricted stock awards, net of forfeitures (shares)       93,486                      
Share-based compensation expense 3,515             3,515              
Restricted stock surrendered due to employee tax liability (680)         $ (680)                  
Restricted stock surrendered due to employee tax liability (shares)       (22,426)   (22,426)                  
Repurchase of common stock (36,068)         $ (36,068)                  
Repurchase of common stock (shares)       (1,600,000)   (1,600,000)                  
Cash dividends declared (common stock, $0.96/share, $0.96/share, $0.00/share) (30,921)                       (30,921)    
Net income 57,868                       57,868    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (4,193)                 (4,193)          
Balance at end of period at Dec. 31, 2018 552,568     $ 33   $ (108,637)   569,712   (6,079)     97,539    
Balance at end of period (ASU 2016-13) at Dec. 31, 2018   $ (12,167)                       $ (12,167)  
Ending balance, shares issued (shares) at Dec. 31, 2018       33,202,369                      
Ending balance, treasury stock (shares) at Dec. 31, 2018           (2,273,932)                  
Ending balance, shares outstanding (shares) at Dec. 31, 2018       30,928,437                      
Adjusted balance at Dec. 31, 2018     $ 551,100   $ 33   $ (116,515)   $ 575,816     $ 3,382     $ 88,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock options exercised 2,979             2,979              
Stock options exercised (shares)       181,900                      
Restricted stock awards, net of forfeitures (shares)       91,133                      
Share-based compensation expense 3,125             3,125              
Restricted stock surrendered due to employee tax liability (517)         $ (517)                  
Restricted stock surrendered due to employee tax liability (shares)       (26,846)   (26,846)                  
Repurchase of common stock (7,362)         $ (7,362)                  
Repurchase of common stock (shares)       (375,000)   (375,000)                  
Cash dividends declared (common stock, $0.96/share, $0.96/share, $0.00/share) (29,776)                       (29,776)    
Net income 32,788                       32,788    
Change in unrealized gain (loss) on securities available for sale, net of income taxes 9,461                 9,461          
Balance at end of period at Dec. 31, 2019 $ 563,267     $ 33   $ (116,515)   575,816   3,382     100,551    
Ending balance, shares issued (shares) at Dec. 31, 2019       33,475,402 33,475,402                    
Ending balance, treasury stock (shares) at Dec. 31, 2019 (2,675,778)         (2,675,778) 2,675,778                
Ending balance, shares outstanding (shares) at Dec. 31, 2019       30,799,624 30,799,624                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Restricted stock awards, net of forfeitures (shares)       85,399                      
Share-based compensation expense $ 2,544             2,544              
Restricted stock surrendered due to employee tax liability (335)         $ (335)                  
Restricted stock surrendered due to employee tax liability (shares)       (31,788)   (31,788)                  
Repurchase of common stock (2,196)         $ (2,196)                  
Repurchase of common stock (shares)       (135,400)   (135,400)                  
Cash dividends declared (common stock, $0.96/share, $0.96/share, $0.00/share) (15,960)                       (15,960)    
Net income 42,196                       42,196    
Change in unrealized gain (loss) on securities available for sale, net of income taxes (306)                 (306)          
Balance at end of period at Dec. 31, 2020 $ 577,044     $ 33   $ (119,046)   $ 578,360   $ 3,076     $ 114,621    
Ending balance, shares issued (shares) at Dec. 31, 2020       33,560,801                      
Ending balance, treasury stock (shares) at Dec. 31, 2020 (2,842,966)         (2,842,966)                  
Ending balance, shares outstanding (shares) at Dec. 31, 2020       30,717,835